跳至主要内容
临床试验/CTRI/2014/07/004716
CTRI/2014/07/004716进行中(未招募)4 期

Randomized, double-blind, clinical trial evaluating low-dose Pioglitazone on glycemic control and insulin resistance in Type-2 Diabetes mellitus: a non-inferiority trial

PGIMER0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
PGIMER
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients on optimal doses of sulfonylurea and /or metformin
  • Age between 25 years and 80 years
  • Either gender
  • FBS < 250 mg/dL
  • HbA1c : 7 - 10 %
  • Patients willing to provide written informed consent

排除标准

  • Diabetes other than type 2 diabetes mellitus
  • Evidence of renal disease (S. creatinine > 1.5mg/ml)
  • Evidence of liver disease (AST/ALT >3 times normal)
  • H/o CCF or IHD
  • Pregnant and lactating mothers and women intending pregnancy
  • History of any hemoglobinopathy that may affect determination of Glycosylated Hemoglobin
  • History of intolerance or hypersensitivity to pioglitazone.
  • Participation in any other clinical trial with in the last 30 days

研究者

发起方
PGIMER

相似试验

进行中(未招募)
不适用
Randomized, double-blind, placebo controlled trial on the efficacy of montelukast in exercise-induced asthma in children - MONTEIAexercise-induced asthma
EUCTR2005-004984-43-ITIVERSITA DEGLI STUDI DI UDINE22
进行中(未招募)
不适用
Study to assess the effectiveness of high doses of immunoglobulin in the treatment of polyneuropathy painful diabetic resistant to conventional therapiespainful diabetic polyneuropathy resistant to conventional therapiesMedDRA version: 14.1Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2010-023883-42-ITAZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE)
进行中(未招募)
不适用
Randomized,double-blind, placebo- controlled trial Phase III to discover efficacy and safety of Diffusil H Forte spray containing carbaryl in patients with pediculosisRandomizovaná,dvojite zaslepená,placebem kontrolovaná klinická studie fáze III s cílem prokázat úcinnost a bezpecnost podání prípravku Diffusil H Forte u pacientu s prokázaným nálezem pedikulózou ve vlasaté cásti hlavy nebo u pacientu, kterí jsou v kontaktu s aktivní pedikulózou v dobe aplikace prípravku
EUCTR2004-001405-10-CZybar a.s.110
已完成
3 期
A clinical trial to study whether zinc decreases the frequency of disease relapses in patients with frequently relapsing nephrotic syndrome
CTRI/2008/091/000057I114
进行中(未招募)
不适用
A clinical trial to compare the effectiveness and safety of treating the initial episode of nephrotic syndrome in children for a duration of three months versus six months
CTRI/2010/091/001095Indian Council of Medical Research168